STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects
- 1 April 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 12 (4), 249-255
- https://doi.org/10.1089/dia.2009.0145
Abstract
Background: Sensor-augmented pump therapy (SAPT) integrates real-time continuous glucose monitoring (RT-CGM) with continuous subcutaneous insulin infusion (CSII) and offers an alternative to multiple daily injections (MDI). Previous studies provide evidence that SAPT may improve clinical outcomes among people with type 1 diabetes. Sensor-Augmented Pump Therapy for A1c Reduction (STAR) 3 is a multicenter randomized controlled trial comparing the efficacy of SAPT to that of MDI in subjects with type 1 diabetes. Methods: Subjects were randomized to either continue with MDI or transition to SAPT for 1 year. Subjects in the MDI cohort were allowed to transition to SAPT for 6 months after completion of the study. SAPT subjects who completed the study were also allowed to continue for 6 months. The primary end point was the difference between treatment groups in change in hemoglobin A1c (HbA1c) percentage from baseline to 1 year of treatment. Secondary end points included percentage of subjects with HbA1c ≤7% and without severe hypoglycemia, as well as area under the curve of time spent in normal glycemic ranges. Tertiary end points include percentage of subjects with HbA1c ≤7%, key safety end points, user satisfaction, and responses on standardized assessments. Results: A total of 495 subjects were enrolled, and the baseline characteristics similar between the SAPT and MDI groups. Study completion is anticipated in June 2010. Conclusions: Results of this randomized controlled trial should help establish whether an integrated RT-CGM and CSII system benefits patients with type 1 diabetes more than MDI.Keywords
This publication has 20 references indexed in Scilit:
- Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisActa Diabetologica, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Use of the Continuous Glucose Monitoring System to Guide Therapy in Patients With Insulin-Treated Diabetes: A Randomized Controlled TrialMayo Clinic Proceedings, 2004
- Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of lifeDiabetic Medicine, 2004
- Modulation of the Inflammatory Response in Cardiovascular DiseaseHypertension, 2004
- Upregulation of CD40–CD40 ligand system in patients with diabetes mellitusClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- The PedsQL™ in Type 1 and Type 2 DiabetesDiabetes Care, 2003
- Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trialBMJ, 2002
- Fear of Hypoglycemia: Quantification, Validation, and UtilizationDiabetes Care, 1987